Sign In
Buy MIRM
$105.95
-6.64 (-5.90%)
At Close: Jul 31, 2026
Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update
04:01pm, Wednesday, 26'th Feb 2025
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today reported financial results for the fourth quarter and year-end 2024 and provided a business update. “2024 was a
Wall Street Analysts Predict a 26.18% Upside in Mirum Pharmaceuticals (MIRM): Here's What You Should Know
10:56am, Wednesday, 26'th Feb 2025
The mean of analysts' price targets for Mirum Pharmaceuticals (MIRM) points to a 26.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement
Mirum's CTEXLI™ (chenodiol) Tablets Receives FDA Approval for Treatment of Cerebrotendinous Xanthomatosis (CTX)
08:30am, Monday, 24'th Feb 2025
FOSTER CITY, Calif.--(BUSINESS WIRE)-- #ctx--Mirum's CTEXLI™ (chenodiol) Tablets Receives FDA Approval for Treatment of Cerebrotendinous Xanthomatosis (CTX).
US FDA approves Mirum Pharma's genetic disorder drug
12:01pm, Friday, 21'st Feb 2025
The U.S. Food and Drug Administration said on Friday it has approved Mirum Pharmaceuticals' drug to treat a type of rare disorder, which affects the body's ability to metabolize fats known as choleste
Mirum Pharmaceuticals to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call on February 26, 2025
04:04pm, Wednesday, 19'th Feb 2025
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call on February 26, 2025.
Mirum Pharmaceuticals (MIRM) is on the Move, Here's Why the Trend Could be Sustainable
09:51am, Monday, 17'th Feb 2025
Mirum Pharmaceuticals (MIRM) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:00pm, Monday, 10'th Feb 2025
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
Recent Price Trend in Mirum Pharmaceuticals (MIRM) is Your Friend, Here's Why
09:50am, Thursday, 30'th Jan 2025
Mirum Pharmaceuticals (MIRM) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Mirum Pharmaceuticals (MIRM) Upgraded to Buy: What Does It Mean for the Stock?
01:01pm, Friday, 24'th Jan 2025
Mirum Pharmaceuticals (MIRM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
MIRM Shares Rise 12% in a Week on Robust Preliminary 2024 Results
01:11pm, Thursday, 16'th Jan 2025
Mirum stock rallies this week on upbeat preliminary 2024 results, the 2025 outlook and anticipated pipeline goals.
Mirum Pharmaceuticals (MIRM) Is a Great Choice for 'Trend' Investors, Here's Why
09:51am, Tuesday, 14'th Jan 2025
If you are looking for stocks that are well positioned to maintain their recent uptrend, Mirum Pharmaceuticals (MIRM) could be a great choice. It is one of the several stocks that passed through our "
Mirum Pharmaceuticals Announces Preliminary Unaudited 2024 Net Product Sales and Cash Balance and Provides Corporate Updates
08:30am, Monday, 13'th Jan 2025
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Announces Preliminary Unaudited 2024 Net Product Sales and Cash Balance and Provides Corporate Updates.
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06:30pm, Friday, 10'th Jan 2025
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
Top 5 Commercial Biotech Buyout Candidates: Mirum Pharmaceuticals (No. 3)
11:05am, Wednesday, 08'th Jan 2025
Top 5 Commercial Biotech Buyout Candidates: Mirum Pharmaceuticals (No. 3)
Mirum Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
04:04pm, Monday, 06'th Jan 2025
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference.
